U.S., April 3 -- ClinicalTrials.gov registry received information related to the study (NCT06906380) titled 'A Long-term Follow-up Study of Patients With ARD103 CAR-T Cell Therapies' on March 26.
Brief Summary: This study will evaluate the long-term safety of ARD103 cellular therapies
Study Start Date: May 07
Study Type: OBSERVATIONAL
Condition:
Acute Myeloid Leukemia, in Relapse
Acute Myeloid Leukemia, in Relapsed or Refractory
MDS (Myelodysplastic Syndrome)
Intervention:
OTHER: Non interventional study
Non Intervention, an observation LTFU study
Recruitment Status: NOT_YET_RECRUITING
Sponsor: ARCE Therapeutics, Inc.
Published by HT Digital Content Services with permission from Health Daily Digest....